OPKO Health Property, Plant, and Equipment 2010-2025 | OPK

OPKO Health property, plant, and equipment from 2010 to 2025. Property, plant, and equipment can be defined as the sum of all net property, plant & Equipment fields. Where companies do not report a break down of plant, property, & equipment, the value is entered in this field alone.
OPKO Health Annual Property, Plant, and Equipment
(Millions of US $)
2024 $70
2023 $75
2022 $83
2021 $80
2020 $141
2019 $127
2018 $145
2017 $147
2016 $123
2015 $132
2014 $16
2013 $17
2012 $17
2011 $5
2010 $3
2009 $1
OPKO Health Quarterly Property, Plant, and Equipment
(Millions of US $)
2025-03-31 $71
2024-12-31 $70
2024-09-30 $72
2024-06-30 $67
2024-03-31 $64
2023-12-31 $75
2023-09-30 $78
2023-06-30 $79
2023-03-31 $81
2022-12-31 $83
2022-09-30 $80
2022-06-30 $79
2022-03-31 $82
2021-12-31 $80
2021-09-30 $108
2021-06-30 $107
2021-03-31 $139
2020-12-31 $141
2020-09-30 $134
2020-06-30 $131
2020-03-31 $127
2019-12-31 $127
2019-09-30 $129
2019-06-30 $137
2019-03-31 $140
2018-12-31 $145
2018-09-30 $147
2018-06-30 $150
2018-03-31 $149
2017-12-31 $147
2017-09-30 $142
2017-06-30 $133
2017-03-31 $126
2016-12-31 $123
2016-09-30 $125
2016-06-30 $128
2016-03-31 $134
2015-12-31 $132
2015-09-30 $127
2015-06-30 $23
2015-03-31 $15
2014-12-31 $16
2014-09-30 $17
2014-06-30 $17
2014-03-31 $17
2013-12-31 $17
2013-09-30 $17
2013-06-30 $17
2013-03-31 $17
2012-12-31 $17
2012-09-30 $13
2012-06-30 $5
2012-03-31 $5
2011-12-31 $5
2011-09-30 $3
2011-06-30 $3
2011-03-31 $3
2010-12-31 $3
2010-09-30 $3
2010-06-30 $3
2010-03-31 $2
2009-12-31 $1
2009-09-30 $1
2009-06-30 $1
2009-03-31 $1
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $0.999B $0.713B
OPKO Health, Inc engages in the diagnostics and pharmaceuticals business in the United States, Ireland, Chile, Spain, Israel and Mexico. The Diagnostics segment operates Bio-Reference Laboratories, a clinical facility that offers testing services in the detection, diagnosis, evaluation, monitoring and treatment of diseases. The company's pharmaceutical business features Rayaldee, an FDA-approved treatment for secondary hyperparathyroidism (SHPT) in adults with stage 3 or 4 chronic kidney disease (CKD) and vitamin D insufficiency and VARUBI for chemotherapy induced nausea and vomiting. OPKO Health has a development and commercial supply pharmaceutical unit in Ireland along with a global supply chain operation and holding wing. The company also owns specialty active pharmaceutical ingredients (APIs) manufacturer in Israel.
Stock Name Country Market Cap PE Ratio
Intuitive Surgical (ISRG) United States $193.381B 84.70
Thermo Fisher Scientific (TMO) United States $148.604B 17.98
Edwards Lifesciences (EW) United States $43.989B 28.84
Alcon (ALC) Switzerland $42.676B 28.84
IDEXX Laboratories (IDXX) United States $40.337B 46.36
DexCom (DXCM) United States $33.137B 51.22
STERIS (STE) Ireland $23.875B 26.33
IQVIA Holdings (IQV) United States $23.701B 13.27
Mettler-Toledo (MTD) United States $23.155B 27.54
Waters (WAT) United States $20.612B 29.08
SONOVA HOLDING (SONVY) Switzerland $19.146B 0.00
Hologic (HOLX) United States $12.096B 13.14
Sysmex ADR (SSMXY) Japan $10.632B 30.16
Penumbra (PEN) United States $10.399B 81.62
Masimo (MASI) United States $8.140B 30.03
Globus Medical (GMED) United States $7.982B 19.02
Glaukos (GKOS) United States $5.487B 0.00
Teleflex (TFX) United States $5.337B 8.81
TransMedics (TMDX) United States $4.203B 91.36
Integer Holdings (ITGR) United States $4.128B 21.63
PROCEPT BioRobotics (PRCT) United States $3.175B 0.00
LivaNova (LIVN) United Kingdom $2.284B 13.60
Veracyte (VCYT) United States $2.127B 29.85
Nihon Kohden (NHNKY) Japan $1.943B 22.28
Elekta AB (EKTAY) Sweden $1.922B 17.28
Alphatec Holdings (ATEC) United States $1.820B 0.00
Tandem Diabetes Care (TNDM) United States $1.380B 0.00
Artivion (AORT) United States $1.222B 114.44
Pulse Biosciences (PLSE) United States $1.136B 0.00
Integra LifeSciences Holdings (IART) United States $0.956B 5.08
SiBone (SIBN) United States $0.783B 0.00
IRadimed (IRMD) United States $0.650B 32.96
RxSight (RXST) United States $0.637B 0.00
Beta Bionics (BBNX) United States $0.626B 0.00
Mesa Laboratories (MLAB) United States $0.597B 13.05
NeuroPace (NPCE) United States $0.580B 0.00
AVANOS MEDICAL, INC (AVNS) United States $0.569B 8.86
Delcath Systems (DCTH) United States $0.561B 0.00
OrthoPediatrics (KIDS) United States $0.506B 0.00
AxoGen (AXGN) United States $0.504B 0.00
Semler Scientific (SMLR) United States $0.494B 13.15
ORTHOFIX MEDICAL INC (OFIX) United States $0.435B 0.00
AngioDynamics (ANGO) United States $0.384B 0.00
Treace Medical Concepts (TMCI) United States $0.370B 0.00
ClearPoint Neuro (CLPT) United States $0.333B 0.00
Pacific Biosciences Of California (PACB) United States $0.277B 0.00
Neuronetics (STIM) United States $0.263B 0.00
Tactile Systems Technology (TCMD) United States $0.219B 13.27
Alpha Tau Medical (DRTS) Israel $0.211B 0.00
Inogen (INGN) United States $0.176B 0.00
Spectral Diagnostics (EDTXF) Canada $0.175B 0.00
CVRx (CVRX) United States $0.174B 0.00
908 Devices (MASS) United States $0.172B 0.00
Lucid Diagnostics (LUCD) United States $0.172B 0.00
Sight Sciences (SGHT) United States $0.165B 0.00
Accuray (ARAY) United States $0.162B 0.00
LENSAR (LNSR) United States $0.160B 0.00
Biosig Technologies (BSGM) United States $0.144B 0.00
Rapid Micro Biosystems (RPID) United States $0.143B 0.00
Anteris Technologies Global (AVR) Australia $0.131B 0.00
Atossa Genetics (ATOS) United States $0.107B 0.00
Microbot Medical (MBOT) United States $0.097B 0.00
Monogram Orthopaedics (MGRM) United States $0.093B 0.00
InspireMD (NSPR) Israel $0.078B 0.00
Sensus Healthcare (SRTS) United States $0.077B 46.90
EDAP TMS S.A (EDAP) France $0.066B 0.00
EnVVeno Medical (NVNO) United States $0.059B 0.00
Covalon Technologies (CVALF) Canada $0.055B 16.67
Hyperfine (HYPR) United States $0.042B 0.00
Vicarious Surgical (RBOT) United States $0.040B 0.00
Spectral AI (MDAI) United States $0.037B 0.00
Envoy Medical (COCH) United States $0.035B 0.00
Precision Optics (POCI) United States $0.033B 0.00
Baird Medical Investment Holdings (BDMD) $0.032B 0.00
DarioHealth (DRIO) United States $0.032B 0.00
Adagio Medical Holdings (ADGM) United States $0.018B 0.00
NexGel (NXGL) United States $0.017B 0.00
PAVmed (PAVM) United States $0.011B 0.00
WORK Medical Technology Group (WOK) China $0.010B 0.00
Ekso Bionics Holdings (EKSO) United States $0.010B 0.00
Tenon Medical (TNON) United States $0.008B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.007B 0.00
Inspira Technologies OXY B.H.N (IINN) Israel $0.006B 0.00
Check-Cap (CHEK) Israel $0.005B 0.00
Autonomix Medical (AMIX) United States $0.004B 0.00
Nuwellis (NUWE) United States $0.004B 0.00
ReShape Lifesciences (RSLS) United States $0.004B 0.00
Venus Concept (VERO) Canada $0.003B 0.00
Bluejay Diagnostics (BJDX) United States $0.003B 0.00
ENDRA Life Sciences (NDRA) United States $0.002B 0.00
Helius Medical Technologies (HSDT) United States $0.002B 0.00
Avinger (AVGR) United States $0.002B 0.00
Nanovibronix (NAOV) United States $0.001B 0.00
Accelerate Diagnostics (AXDX) United States $0.001B 0.00
Longview Acquisition II (LGV) United States $0.000B 0.00
Fresenius Medical Care AG KGaA (FMS) Germany $0.000B 16.58
Spinal Elements Holdings (SPEL) United States $0.000B 0.00